{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:13:26Z","timestamp":1791461606911,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Doxorubicin (DOX) is a commonly used chemotherapeutic medication for treating malignancies, although its cardiotoxicity limits its use. There is growing evidence that alteration of the mitochondrial fission\/fusion dynamic processes accompanied by excessive reactive oxygen species (ROS) production and alteration of calcium Ca<jats:sup>2+<\/jats:sup> homeostasis are potential underlying mechanisms of DOX-induced cardiotoxicity (DIC). Metformin (Met) is an AMP-activated protein kinase (AMPK) activator that has antioxidant properties and cardioprotective effects. The purpose of the study is to assess Met's possible cardioprotective benefits against DOX-induced cardiotoxicity. The study included 32 adult male rats. They were randomly divided into four groups: administered saline, DOX, Met, or DOX combined with Met respectively. Heart tissues were used for biochemical assays that measured oxidative stress markers, malondialdehyde (MDA), reduced glutathione (GSH), mitochondrial dynamics markers, optic atrophy-1(OPA-1) and dynamin-1-like protein (Drp1), calcineurin and caspase-3. Serum levels of myocardial injury markers, cardiac troponin I (cTn-I), and aspartate aminotransferase (AST), were also measured. The results revealed that DOX intoxication was associated with a significant increase in the levels of serum cTn-I and AST, increased cardiac MDA level, increased cardiac Drp1, calcineurin, and caspase-3 expressions, as well as reduced cardiac GSH level and cardiac OPA-1 expression. On the other hand, Met treatment significantly reduced DIC by decreasing oxidative stress, apoptosis, and improving mitochondrial and calcium balance. Finally, this study shows that Met may be able to protect the heart from damage caused by DOX by working as an antioxidant and anti-apoptotic agent and keeping the balance of calcium and mitochondria.<\/jats:p>","DOI":"10.1007\/s12010-024-05141-9","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T08:57:50Z","timestamp":1736499470000},"page":"2713-2733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Metformin Alleviates Doxorubicin-Induced Cardiotoxicity via Preserving Mitochondrial Dynamics Balance and Calcium Homeostasis"],"prefix":"10.1007","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8631-9543","authenticated-orcid":false,"given":"Nashwa","family":"Maghraby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A. H.","family":"EL-Baz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athar M. A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sary Kh.","family":"Abd- elghaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Sabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"5141_CR1","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1074\/jbc.RA119.011571","volume":"295","author":"P Xia","year":"2020","unstructured":"Xia, P., Chen, J., Liu, Y., Fletcher, M., Jensen, B. C., & Cheng, Z. (2020). Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2\u2013mediated activation of forkhead box O1. Journal of Biological Chemistry, 295, 4265\u20134276.","journal-title":"Journal of Biological Chemistry"},{"key":"5141_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","volume":"12","author":"E Christidi","year":"2021","unstructured":"Christidi, E., & Brunham, L. R. (2021). Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death & Disease, 12, 339.","journal-title":"Cell Death & Disease"},{"key":"5141_CR3","doi-asserted-by":"publisher","unstructured":"Harahap, Y., Ardiningsih, P., Corintias Winarti, A., & Purwanto, D. J. (2020). Analysis of the doxorubicin and doxorubicinol in the plasma of breast cancer patients for monitoring the toxicity of doxorubicin. Drug Design, Development and Therapy, 3469\u20133475.\u200f https:\/\/doi.org\/10.2147\/DDDT.S251144","DOI":"10.2147\/DDDT.S251144"},{"key":"5141_CR4","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., & Curigliano, G. (2015). Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation, 131, 1981\u20131988.","journal-title":"Circulation"},{"key":"5141_CR5","first-page":"e004560","volume":"11","author":"JH Jordan","year":"2018","unstructured":"Jordan, J. H., Castellino, S. M., Mel\u00e9ndez, G. C., Klepin, H. D., Ellis, L. R., Lamar, Z., Vasu, S., Kitzman, D. W., Ntim, W. O., & Brubaker, P. H. (2018). Left ventricular mass change after anthracycline chemotherapy. Circulation: Heart Failure, 11, e004560.","journal-title":"Circulation: Heart Failure"},{"key":"5141_CR6","first-page":"e005234","volume":"12","author":"MS Willis","year":"2019","unstructured":"Willis, M. S., Parry, T. L., Brown, D. I., Mota, R. I., Huang, W., Beak, J. Y., Sola, M., Zhou, C., Hicks, S. T., & Caughey, M. C. (2019). Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle\u2013specific ubiquitin ligase MuRF1. Circulation: Heart Failure, 12, e005234.","journal-title":"Circulation: Heart Failure"},{"key":"5141_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014). Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. The Journal of Clinical Investigation, 124, 617\u2013630.","journal-title":"The Journal of Clinical Investigation"},{"key":"5141_CR8","doi-asserted-by":"publisher","first-page":"114743","DOI":"10.1016\/j.bcp.2021.114743","volume":"192","author":"A Arinno","year":"2021","unstructured":"Arinno, A., Maneechote, C., Khuanjing, T., Ongnok, B., Prathumsap, N., Chunchai, T., Arunsak, B., Kerdphoo, S., Shinlapawittayatorn, K., & Chattipakorn, S. C. (2021). Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics. Biochemical Pharmacology, 192, 114743.","journal-title":"Biochemical Pharmacology"},{"key":"5141_CR9","doi-asserted-by":"publisher","first-page":"119527","DOI":"10.1016\/j.lfs.2021.119527","volume":"278","author":"S Sritharan","year":"2021","unstructured":"Sritharan, S., & Sivalingam, N. (2021). A comprehensive review on time-tested anticancer drug doxorubicin. Life Sciences, 278, 119527.","journal-title":"Life Sciences"},{"key":"5141_CR10","doi-asserted-by":"publisher","first-page":"6534","DOI":"10.1111\/jcmm.15305","volume":"24","author":"N Osataphan","year":"2020","unstructured":"Osataphan, N., Phrommintikul, A., Chattipakorn, S. C., & Chattipakorn, N. (2020). Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions. Journal of Cellular and Molecular Medicine, 24, 6534\u20136557.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"5141_CR11","doi-asserted-by":"publisher","first-page":"534124","DOI":"10.3389\/fendo.2020.00374","volume":"11","author":"R Yu","year":"2020","unstructured":"Yu, R., Lendahl, U., Nist\u00e9r, M., & Zhao, J. (2020). Regulation of mammalian mitochondrial dynamics: Opportunities and challenges. Frontiers in Endocrinology, 11, 534124.","journal-title":"Frontiers in Endocrinology"},{"key":"5141_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-021-01161-7","volume":"19","author":"R Yu","year":"2021","unstructured":"Yu, R., Liu, T., Jin, S.-B., Ankarcrona, M., Lendahl, U., Nist\u00e9r, M., & Zhao, J. (2021). MIEF1\/2 orchestrate mitochondrial dynamics through direct engagement with both the fission and fusion machineries. BMC Biology, 19, 1\u201322.","journal-title":"BMC Biology"},{"key":"5141_CR13","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.1096\/fj.201802663R","volume":"33","author":"MP Catanzaro","year":"2019","unstructured":"Catanzaro, M. P., Weiner, A., Kaminaris, A., Li, C., Cai, F., Zhao, F., Kobayashi, S., Kobayashi, T., Huang, Y., & Sesaki, H. (2019). Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy. The FASEB Journal, 33, 11096.","journal-title":"The FASEB Journal"},{"key":"5141_CR14","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3390\/cells11132000","volume":"11","author":"L Schirone","year":"2022","unstructured":"Schirone, L., D\u2019Ambrosio, L., Forte, M., Genovese, R., Schiavon, S., Spinosa, G., Iacovone, G., Valenti, V., Frati, G., & Sciarretta, S. (2022). Mitochondria and doxorubicin-induced cardiomyopathy: A complex interplay. Cells, 11, 2000.","journal-title":"Cells"},{"key":"5141_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","volume":"307","author":"M Songbo","year":"2019","unstructured":"Songbo, M., Lang, H., Xinyong, C., Bin, X., Ping, Z., & Liang, S. (2019). Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicology Letters, 307, 41\u201348.","journal-title":"Toxicology Letters"},{"key":"5141_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s12012-021-09655-0","volume":"21","author":"V Vadavanath Prabhakaran","year":"2021","unstructured":"Vadavanath Prabhakaran, V., & Kozhiparambil Gopalan, R. (2021). Phloretin alleviates arsenic trioxide-induced apoptosis of H9c2 cardiomyoblasts via downregulation in Ca2+\/calcineurin\/NFATc pathway and inflammatory cytokine release. Cardiovascular Toxicology, 21, 642\u2013654.","journal-title":"Cardiovascular Toxicology"},{"key":"5141_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/ijms24010343","volume":"24","author":"Q Sun","year":"2022","unstructured":"Sun, Q., Jia, H., Cheng, S., Wang, Y., & Wang, J. (2022). Metformin alleviates epirubicin-induced endothelial impairment by restoring mitochondrial homeostasis. International Journal of Molecular Sciences, 24, 343.","journal-title":"International Journal of Molecular Sciences"},{"key":"5141_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-5-6","volume":"5","author":"LBA Rojas","year":"2013","unstructured":"Rojas, L. B. A., & Gomes, M. B. (2013). Metformin: An old but still the best treatment for type 2 diabetes. Diabetology & Metabolic Syndrome, 5, 1\u201315.","journal-title":"Diabetology & Metabolic Syndrome"},{"key":"5141_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2174\/1381612826666201222154616","volume":"27","author":"M Grammatiki","year":"2021","unstructured":"Grammatiki, M., Sagar, R., & Ajjan, R. A. (2021). Metformin: Is it still the first line in type 2 diabetes management algorithm? Current Pharmaceutical Design, 27, 1061\u20131067.","journal-title":"Current Pharmaceutical Design"},{"key":"5141_CR20","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/molecules23051184","volume":"23","author":"R Zilinyi","year":"2018","unstructured":"Zilinyi, R., Czompa, A., Czegledi, A., Gajtko, A., Pituk, D., Lekli, I., & Tosaki, A. (2018). The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: The role of autophagy. Molecules, 23, 1184.","journal-title":"Molecules"},{"key":"5141_CR21","first-page":"683","volume":"15","author":"F Zi","year":"2018","unstructured":"Zi, F., Zi, H., Li, Y., He, J., Shi, Q., & Cai, Z. (2018). Metformin and cancer: An existing drug for cancer prevention and therapy. Oncology Letters, 15, 683\u2013690.","journal-title":"Oncology Letters"},{"key":"5141_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/aimj.2021.70828.1454","volume":"2","author":"AA Agaba","year":"2021","unstructured":"Agaba, A. A., Ebada, M. M., & Emara, H. M. (2021). Protective Effect of Metformin on Doxorubicin-induced Cardiomyopathy in the Adult Male Albino Rats (Light and Electron Microscopic Study). Al-Azhar International Medical Journal, 2, 1\u20138.","journal-title":"Al-Azhar International Medical Journal"},{"key":"5141_CR23","doi-asserted-by":"publisher","unstructured":"Ashour, A. E., Sayed-Ahmed, M. M., Abd-Allah, A. R., Korashy, H. M., Maayah, Z. H., Alkhalidi, H., Mubarak, M., & Alhaider, A. (2012). Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats. Oxidative Medicine and Cellular Longevity, 2012. https:\/\/doi.org\/10.1155\/2012\/434195","DOI":"10.1155\/2012\/434195"},{"key":"5141_CR24","first-page":"234","volume":"16","author":"M Argun","year":"2016","unstructured":"Argun, M., \u00dcz\u00fcm, K., S\u00f6nmez, M. F., \u00d6zyurt, A., Derya, K., \u00c7ilenk, K. T., Unalm\u0131\u015f, S., Pamukcu, \u00d6., Baykan, A., & Narin, F. (2016). Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats. Anatolian Journal of Cardiology, 16, 234\u2013241.","journal-title":"Anatolian Journal of Cardiology"},{"key":"5141_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12882-023-03427-4","volume":"24","author":"MS Sabra","year":"2023","unstructured":"Sabra, M. S., Hemida, F. K., & Allam, E. A. (2023). Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive. BMC Nephrology, 24, 377.","journal-title":"BMC Nephrology"},{"key":"5141_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1369\/0022155416649579","volume":"64","author":"C Perry","year":"2016","unstructured":"Perry, C., Chung, J.-Y., Ylaya, K., Choi, C. H., Simpson, A., Matsumoto, K. T., Smith, W. A., & Hewitt, S. M. (2016). A buffered alcohol-based fixative for histomorphologic and molecular applications. Journal of Histochemistry & Cytochemistry, 64, 425\u2013440.","journal-title":"Journal of Histochemistry & Cytochemistry"},{"key":"5141_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/path.1711710205","volume":"171","author":"G Cattoretti","year":"1993","unstructured":"Cattoretti, G., Pileri, S., Parravicini, C., Becker, M. H., Poggi, S., Bifulco, C., Key, G., D\u2019Amato, L., Sabattini, E., & Feudale, E. (1993). Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. The Journal of Pathology, 171, 83\u201398.","journal-title":"The Journal of Pathology"},{"key":"5141_CR28","first-page":"193","volume":"37","author":"AI Helal","year":"2020","unstructured":"Helal, A. I., Helal, O., Metwaly, H., Abo Gazia, M., & Mohamed, O. (2020). Histological and immunohistochemical study on the possible therapeutic role of stem cells and curcumin in cyclophosphamide-induced cardiotoxicity in adult male albino rat. Benha Medical Journal, 37, 193\u2013206.","journal-title":"Benha Medical Journal"},{"issue":"1","key":"5141_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s40001-022-00747-3","volume":"27","author":"MM Hamdy","year":"2022","unstructured":"Hamdy, M. M., Abdel-Rahman, M. S., Badary, D. M., & Sabra, M. S. (2022). Effects of furosemide and tadalafil in both conventional and nanoforms against adenine-induced chronic renal failure in rats. European Journal of Medical Research, 27(1), 117.","journal-title":"European Journal of Medical Research"},{"issue":"1","key":"5141_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40360-024-00795-x","volume":"25","author":"EA Allam","year":"2024","unstructured":"Allam, E. A., Darwish, M. H., Abou Khalil, N. S., El-Baset, S. H. A., El-Aal, M. A., Elrawy, A., Ahmed, A. A., & Sabra, M. S. (2024). Evaluation of the therapeutic potential of novel nanoparticle formulations of glutathione and virgin coconut oil in an experimental model of carbon tetrachloride-induced liver failure. BMC Pharmacology and Toxicology, 25(1), 74.","journal-title":"BMC Pharmacology and Toxicology"},{"key":"5141_CR31","doi-asserted-by":"publisher","unstructured":"Sabra, M. S., Allam, E. A., El-Aal, M. A., Hassan, N. H., Mostafa, A. H. M., & Ahmed, A. A. (2024). A novel pharmacological strategy using nanoparticles with glutathione and virgin coconut oil to treat gentamicin-induced acute renal failure in rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 1\u201318. https:\/\/doi.org\/10.1007\/s00210-024-03303-4","DOI":"10.1007\/s00210-024-03303-4"},{"key":"5141_CR32","doi-asserted-by":"publisher","unstructured":"Sabra, M. S., Allam, E. A., & Hassanein, K. M. A. (2024). Sildenafil and furosemide nanoparticles as a novel pharmacological treatment for acute renal failure in rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 1\u201315. https:\/\/doi.org\/10.1007\/s00210-024-03128-1","DOI":"10.1007\/s00210-024-03128-1"},{"key":"5141_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods, 25, 402\u2013408.","journal-title":"Methods"},{"key":"5141_CR34","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012). Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology, 52, 1213\u20131225.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"5141_CR35","doi-asserted-by":"publisher","first-page":"104542","DOI":"10.1016\/j.phrs.2019.104542","volume":"151","author":"J Benjanuwattra","year":"2020","unstructured":"Benjanuwattra, J., Siri-Angkul, N., Chattipakorn, S. C., & Chattipakorn, N. (2020). Doxorubicin and its proarrhythmic effects: A comprehensive review of the evidence from experimental and clinical studies. Pharmacological Research, 151, 104542.","journal-title":"Pharmacological Research"},{"key":"5141_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1124\/mol.119.115725","volume":"96","author":"N Wenningmann","year":"2019","unstructured":"Wenningmann, N., Knapp, M., Ande, A., Vaidya, T. R., & Ait-Oudhia, S. (2019). Insights into doxorubicin-induced cardiotoxicity: Molecular mechanisms, preventive strategies, and early monitoring. Molecular Pharmacology, 96, 219\u2013232.","journal-title":"Molecular Pharmacology"},{"issue":"43","key":"5141_CR37","doi-asserted-by":"publisher","first-page":"33585","DOI":"10.1074\/jbc.M003890200","volume":"275","author":"S Kotamraju","year":"2000","unstructured":"Kotamraju, S., Konorev, E. A., Joseph, J., & Kalyanaraman, B. (2000). Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen: Role of reactive oxygen and nitrogen species. Journal of Biological Chemistry, 275(43), 33585\u201333592.","journal-title":"Journal of Biological Chemistry"},{"key":"5141_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/FJC.0000000000000599","volume":"72","author":"C Driver","year":"2018","unstructured":"Driver, C., Bamitale, K. D., Kazi, A., Olla, M., Nyane, N. A., & Owira, P. M. (2018). Cardioprotective effects of metformin. Journal of Cardiovascular Pharmacology, 72, 121\u2013127.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"5141_CR39","doi-asserted-by":"publisher","first-page":"490991","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv, Z., & Guo, Y. (2020). Metformin and its benefits for various diseases. Frontiers in Endocrinology, 11, 490991.","journal-title":"Frontiers in Endocrinology"},{"key":"5141_CR40","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","volume":"76","author":"L Wang","year":"2016","unstructured":"Wang, L., Chen, Q., Qi, H., Wang, C., Wang, C., Zhang, J., & Dong, L. (2016). Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage. Cancer Research, 76, 6631\u20136642.","journal-title":"Cancer Research"},{"key":"5141_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12012-023-09784-8","volume":"23","author":"SM Satyam","year":"2023","unstructured":"Satyam, S. M., Bairy, L. K., Shetty, P., Sainath, P., Bharati, S., Ahmed, A. Z., Singh, V. K., & Ashwal, A. (2023). Metformin and dapagliflozin attenuate doxorubicin-induced acute cardiotoxicity in wistar rats: An Electrocardiographic, Biochemical, and Histopathological Approach. Cardiovascular Toxicology, 23, 107\u2013119.","journal-title":"Cardiovascular Toxicology"},{"key":"5141_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jtemb.2018.01.016","volume":"47","author":"S Sangomla","year":"2018","unstructured":"Sangomla, S., Saifi, M. A., Khurana, A., & Godugu, C. (2018). Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation. Journal of Trace Elements in Medicine and Biology, 47, 53\u201362.","journal-title":"Journal of Trace Elements in Medicine and Biology"},{"key":"5141_CR43","doi-asserted-by":"publisher","first-page":"109547","DOI":"10.1016\/j.biopha.2019.109547","volume":"122","author":"W Qi","year":"2020","unstructured":"Qi, W., Boliang, W., Xiaoxi, T., Guoqiang, F., Jianbo, X., & Gang, W. (2020). Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling. Biomedicine & Pharmacotherapy, 122, 109547.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"5141_CR44","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00280-017-3413-7","volume":"80","author":"MM Abdel-Daim","year":"2017","unstructured":"Abdel-Daim, M. M., Kilany, O. E., Khalifa, H. A., & Ahmed, A. A. (2017). Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Cancer Chemotherapy and Pharmacology, 80, 745\u2013753.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"5141_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","volume":"21","author":"CF Thorn","year":"2011","unstructured":"Thorn, C. F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T. E., & Altman, R. B. (2011). Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenetics and Genomics, 21, 440\u2013446.","journal-title":"Pharmacogenetics and Genomics"},{"key":"5141_CR46","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.bbamcr.2011.03.002","volume":"1813","author":"AV Kuznetsov","year":"2011","unstructured":"Kuznetsov, A. V., Margreiter, R., Amberger, A., Saks, V., & Grimm, M. (2011). Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1813, 1144\u20131152.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"key":"5141_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1007094214460","volume":"207","author":"P Singal","year":"2000","unstructured":"Singal, P., Li, T., Kumar, D., Danelisen, I., & Iliskovic, N. (2000). Adriamycin-induced heart failure: Mechanisms and modulation. Molecular and Cellular Biochemistry, 207, 77\u201386.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"5141_CR48","doi-asserted-by":"publisher","first-page":"929302","DOI":"10.3389\/fphar.2022.929302","volume":"13","author":"X Yi","year":"2022","unstructured":"Yi, X., Wang, F., Feng, Y., Zhu, J., & Wu, Y. (2022). Danhong injection attenuates doxorubicin-induced cardiotoxicity in rats via suppression of apoptosis: Network pharmacology analysis and experimental validation. Frontiers in Pharmacology, 13, 929302.","journal-title":"Frontiers in Pharmacology"},{"key":"5141_CR49","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/09603271211010896","volume":"40","author":"AS Hekmat","year":"2021","unstructured":"Hekmat, A. S., Navabi, Z., Alipanah, H., & Javanmardi, K. (2021). Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats. Human & Experimental Toxicology, 40, 1781\u20131795.","journal-title":"Human & Experimental Toxicology"},{"key":"5141_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/15376516.2021.1972375","volume":"32","author":"AS Saleh Ahmed","year":"2022","unstructured":"Saleh Ahmed, A. S. (2022). Potential protective effect of catechin on doxorubicin-induced cardiotoxicity in adult male albino rats. Toxicology Mechanisms and Methods, 32, 97\u2013105.","journal-title":"Toxicology Mechanisms and Methods"},{"issue":"7","key":"5141_CR51","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.arcmed.2016.11.008","volume":"47","author":"HA Dundar","year":"2016","unstructured":"Dundar, H. A., Kiray, M., Kir, M., Kolatan, E., Bagriyanik, A., Altun, Z., Aktas, S., Ellidokuz, H., Yilmaz, O., Mutafoglu, K., & Olgun, N. (2016). Protective effect of acetyl-L-carnitine against doxorubicin-induced cardiotoxicity in wistar albino rats. Archives of Medical Research, 47(7), 506\u2013514.","journal-title":"Archives of Medical Research"},{"key":"5141_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jconrel.2017.11.024","volume":"269","author":"J Abe","year":"2018","unstructured":"Abe, J., Yamada, Y., Takeda, A., & Harashima, H. (2018). Cardiac progenitor cells activated by mitochondrial delivery of resveratrol enhance the survival of a doxorubicin-induced cardiomyopathy mouse model via the mitochondrial activation of a damaged myocardium. Journal of Controlled Release, 269, 177\u2013188.","journal-title":"Journal of Controlled Release"},{"issue":"23","key":"5141_CR53","doi-asserted-by":"publisher","first-page":"8589","DOI":"10.3390\/molecules27238589","volume":"27","author":"AAM Alkhanjaf","year":"2022","unstructured":"Alkhanjaf, A. A. M., Athar, M. T., Ullah, Z., Alsayhab, A. M. H., Umar, A., & Shaikh, I. A. (2022). Farnesol protects against cardiotoxicity caused by doxorubicin-induced stress, inflammation, and cell death: An in vivo study in wistar rats. Molecules, 27(23), 8589.","journal-title":"Molecules"},{"key":"5141_CR54","doi-asserted-by":"publisher","unstructured":"Li, Y., Lin, R., Peng, X., Wang, X., Liu, X., Li, L., Bai, R., Wen, S., Ruan, Y., & Chang, X. (2022). The role of mitochondrial quality control in anthracycline-induced cardiotoxicity: From bench to bedside.\u00a0Oxidative Medicine and Cellular Longevity,\u00a02022. https:\/\/doi.org\/10.1155\/2022\/3659278","DOI":"10.1155\/2022\/3659278"},{"key":"5141_CR55","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.1002\/jcp.27597","volume":"234","author":"FG Tahrir","year":"2019","unstructured":"Tahrir, F. G., Langford, D., Amini, S., Mohseni Ahooyi, T., & Khalili, K. (2019). Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease. Journal of Cellular Physiology, 234, 8122\u20138133.","journal-title":"Journal of Cellular Physiology"},{"key":"5141_CR56","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1038\/s41598-022-10004-6","volume":"12","author":"FJ Detmer","year":"2022","unstructured":"Detmer, F. J., Alpert, N. M., Moon, S.-H., Dhaynaut, M., Guerrero, J. L., Guehl, N. J., Xing, F., Brugarolas, P., Shoup, T. M., & Normandin, M. D. (2022). PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: A proof-of-principle study. Scientific Reports, 12, 6122.","journal-title":"Scientific Reports"},{"key":"5141_CR57","doi-asserted-by":"crossref","unstructured":"Singh, M., Nicol, A. T., DelPozzo, J., Wei, J., Singh, M., Nguyen, T., ..., & Liang, Q. (2022). Demystifying the relationship between metformin, AMPK, and doxorubicin cardiotoxicity. Frontiers in Cardiovascular Medicine, 9, 839644.\u200f","DOI":"10.3389\/fcvm.2022.839644"},{"issue":"1","key":"5141_CR58","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tips.2022.10.003","volume":"44","author":"L Wu","year":"2023","unstructured":"Wu, L., Wang, L., Du, Y., Zhang, Y., & Ren, J. (2023). Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity. Trends in Pharmacological Sciences, 44(1), 34-49.47.","journal-title":"Trends in Pharmacological Sciences"},{"key":"5141_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","volume":"27","author":"T Wai","year":"2016","unstructured":"Wai, T., & Langer, T. (2016). Mitochondrial dynamics and metabolic regulation. Trends in Endocrinology & Metabolism, 27, 105\u2013117.","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"5141_CR60","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014). Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological Reviews, 94, 909\u2013950.","journal-title":"Physiological Reviews"},{"key":"5141_CR61","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3389\/fphar.2020.00815","volume":"11","author":"L Li","year":"2020","unstructured":"Li, L., Li, J., Wang, Q., Zhao, X., Yang, D., Niu, L., Yang, Y., Zheng, X., Hu, L., & Li, Y. (2020). Shenmai injection protects against doxorubicin-induced cardiotoxicity via maintaining mitochondrial homeostasis. Frontiers in Pharmacology, 11, 815.","journal-title":"Frontiers in Pharmacology"},{"key":"5141_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1042\/CS20220074","volume":"136","author":"C Maneechote","year":"2022","unstructured":"Maneechote, C., Khuanjing, T., Ongnok, B., Arinno, A., Prathumsap, N., Chunchai, T., Arunsak, B., Nawara, W., Chattipakorn, S. C., & Chattipakorn, N. (2022). Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: A novel therapeutic target for cardioprotection. Clinical Science, 136, 841\u2013860.","journal-title":"Clinical Science"},{"key":"5141_CR63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/157339611796892265","volume":"7","author":"J Shi","year":"2011","unstructured":"Shi, J., Abdelwahid, E., & Wei, L. (2011). Apoptosis in anthracycline cardiomyopathy. Current Pediatric Reviews, 7, 329\u2013336.","journal-title":"Current Pediatric Reviews"},{"key":"5141_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcha.2015.11.004","volume":"10","author":"MA Mitry","year":"2016","unstructured":"Mitry, M. A., & Edwards, J. G. (2016). Doxorubicin induced heart failure: Phenotype and molecular mechanisms. IJC Heart & Vasculature, 10, 17\u201324.","journal-title":"IJC Heart & Vasculature"},{"key":"5141_CR65","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/BJ20050285","volume":"389","author":"SV Kalivendi","year":"2005","unstructured":"Kalivendi, S. V., Konorev, E. A., Cunningham, S., Vanamala, S. K., Kaji, E. H., Joseph, J., & Kalyanaraman, B. (2005). Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: Role of mitochondrial reactive oxygen species and calcium. Biochemical Journal, 389, 527\u2013539.","journal-title":"Biochemical Journal"},{"key":"5141_CR66","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/1440-1681.13225","volume":"47","author":"AA Shati","year":"2020","unstructured":"Shati, A. A. (2020). Doxorubicin-induces NFAT\/Fas\/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways. Clinical and Experimental Pharmacology and Physiology, 47, 660\u2013676.","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"5141_CR67","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1124\/mol.114.093849","volume":"86","author":"AD Hanna","year":"2014","unstructured":"Hanna, A. D., Lam, A., Tham, S., Dulhunty, A. F., & Beard, N. A. (2014). Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A. Molecular Pharmacology, 86, 438\u2013449.","journal-title":"Molecular Pharmacology"},{"key":"5141_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40816-021-00265-5","volume":"7","author":"DaA Ibrahim","year":"2021","unstructured":"Ibrahim, Da. A., Almutawakel, M. A., & Al-Badani, R. (2021). Cardioprotective effect of Malva verticillata against doxorubicin-induced toxicity in rats. Clinical Phytoscience, 7, 1\u20139.","journal-title":"Clinical Phytoscience"},{"key":"5141_CR69","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/med.21280","volume":"34","author":"FS Carvalho","year":"2014","unstructured":"Carvalho, F. S., Burgeiro, A., Garcia, R., Moreno, A. J., Carvalho, R. A., & Oliveira, P. J. (2014). Doxorubicin-induced cardiotoxicity: From bioenergetic failure and cell death to cardiomyopathy. Medicinal Research Reviews, 34, 106\u2013135.","journal-title":"Medicinal Research Reviews"},{"key":"5141_CR70","doi-asserted-by":"publisher","first-page":"811406","DOI":"10.3389\/fphar.2022.811406","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang, J., Wu, R., Chen, L., Yang, Z., Yan, D., & Li, M. (2022). Understanding anthracycline cardiotoxicity from mitochondrial aspect. Frontiers in Pharmacology, 13, 811406.","journal-title":"Frontiers in Pharmacology"},{"key":"5141_CR71","doi-asserted-by":"publisher","first-page":"15803","DOI":"10.1073\/pnas.0808249105","volume":"105","author":"G Cereghetti","year":"2008","unstructured":"Cereghetti, G., Stangherlin, A., De Brito, O. M., Chang, C., Blackstone, C., Bernardi, P., & Scorrano, L. (2008). Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proceedings of the National Academy of Sciences, 105, 15803\u201315808.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"5141_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/molecules26010053","volume":"26","author":"JJ Yoon","year":"2020","unstructured":"Yoon, J. J., Son, C. O., Kim, H. Y., Han, B. H., Lee, Y. J., Lee, H. S., & Kang, D. G. (2020). Betulinic acid protects DOX-triggered cardiomyocyte hypertrophy response through the GATA-4\/calcineurin\/NFAT pathway. Molecules, 26, 53.","journal-title":"Molecules"},{"issue":"2","key":"5141_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijcard.2010.04.008","volume":"150","author":"H Sharma","year":"2011","unstructured":"Sharma, H., Pathan, R. A., Kumar, V., Javed, S., & Bhandari, U. (2011). Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy. International Journal of Cardiology, 150(2), 193\u2013200.","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"5141_CR74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.bjp.0703336","volume":"130","author":"MM Mocanu","year":"2000","unstructured":"Mocanu, M. M., Baxter, G. F., & Yellon, D. M. (2000). Caspase inhibition and limitation of myocardial infarct size: Protection against lethal reperfusion injury. British Journal of Pharmacology, 130(2), 197\u2013200.","journal-title":"British Journal of Pharmacology"},{"key":"5141_CR75","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s002100100483","volume":"364","author":"P Kovacs","year":"2001","unstructured":"Kovacs, P., Bak, I., Szendrei, L., Vecsernyes, M., Varga, E., Blasig, I. E., & Tosaki, A. (2001). Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic\/reperfused rat hearts. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 364, 501\u2013507.","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"11","key":"5141_CR76","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1177\/0960327115627685","volume":"35","author":"A Sheta","year":"2016","unstructured":"Sheta, A., Elsakkar, M., Hamza, M., & Solaiman, A. (2016). Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in adult male albino rats. Human & Experimental Toxicology, 35(11), 1227\u20131239.","journal-title":"Human & Experimental Toxicology"},{"key":"5141_CR77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2013.11.003","volume":"67","author":"MC Asensio-Lopez","year":"2014","unstructured":"Asensio-Lopez, M. C., Sanchez-Mas, J., Pascual-Figal, D. A., de Torre, C., Valdes, M., & Lax, A. (2014). Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes. Free Radical Biology and Medicine, 67, 19\u201329.","journal-title":"Free Radical Biology and Medicine"},{"issue":"1","key":"5141_CR78","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41598-023-51083-3","volume":"14","author":"HJ Zhang","year":"2024","unstructured":"Zhang, H. J., Fu, Y., Zhang, H., Lai, Z. Q., & Dong, Y. F. (2024). Sophocarpine alleviates doxorubicin-induced heart injury by suppressing oxidative stress and apoptosis. Scientific Reports, 14(1), 428.","journal-title":"Scientific Reports"},{"key":"5141_CR79","doi-asserted-by":"publisher","first-page":"124122","DOI":"10.3389\/fmolb.2023.1241225","volume":"10","author":"R Chen","year":"2023","unstructured":"Chen, R., Niu, M., Hu, X., & He, Y. (2023). Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity. Frontiers in Molecular Biosciences, 10, 124122.","journal-title":"Frontiers in Molecular Biosciences"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05141-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-024-05141-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05141-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T09:35:56Z","timestamp":1744277756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-024-05141-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5141"],"URL":"https:\/\/doi.org\/10.1007\/s12010-024-05141-9","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"24 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed according to the principles and guidelines given by the Animal Research Ethics Committee, Faculty of Medicine, Assiut University (26\/6\/2023, IRB local approval number 04\u20132023-300201).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}